Usage of triptans among migraine patients: An audit in nine GP practices

Current Medical Research and Opinion

Volumn 18, Issue 1, 2002, Pages 1-9

  Williams, D ^a   Cahill, T ^a   Dowson, A ^a   Fearon, H ^a   Lipscombe, S ^a   O'Sullivan, E ^a   Rees, T ^a   Strang, C ^a   Valori, A ^a   Watson, D ^a  

^a Willows Surgery   (United Kingdom)

Author keywords

Audit; Drug therapy; Migraine; Primary care; Therapeutic use; Triptan

Indexed keywords

ALMOTRIPTAN; ANTIMIGRAINE AGENT; NARATRIPTAN; RIZATRIPTAN; SEROTONIN AGONIST; SUMATRIPTAN; ZOLMITRIPTAN;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; FEMALE; GENERAL PRACTITIONER; HEADACHE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD; MIGRAINE; PATIENT CARE; PATIENT EDUCATION; PATIENT MONITORING; PREDICTION; PRESCRIPTION; QUESTIONNAIRE; TABLET; UNITED KINGDOM;

EID: 0036210795     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079902125000084     Document Type: Article

References (18)

1. The epidemiology of migraine
2. The UK Migraine Patient Survey: Quality of life and treatment
3. Migraine: Which triptan?
4. Migraine
5. A systematic review of the use of triptans in acute migraine
6. Eletriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan
7. Comparisons of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine
8. Oral almotriptan in the treatment of migraine: Safety and tolerability
9. The clinical and financial impact of oral triptans in the management of migraine in the UK a systematic review
10. Analgesic headache
11. Ergotamine dependency: A review
12. The chi square distribution
13. The diagnosis and treatment of migraine: A clinician's view
14. Sumatriptan in clinical practice: A two-year review of 453 migraine patients
15. Drug-induced headache